Does USTEKINUMAB Cause Thrombocytopenia? 211 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 211 reports of Thrombocytopenia have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.3% of all adverse event reports for USTEKINUMAB.
211
Reports of Thrombocytopenia with USTEKINUMAB
0.3%
of all USTEKINUMAB reports
102
Deaths
118
Hospitalizations
How Dangerous Is Thrombocytopenia From USTEKINUMAB?
Of the 211 reports, 102 (48.3%) resulted in death, 118 (55.9%) required hospitalization, and 106 (50.2%) were considered life-threatening.
Is Thrombocytopenia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 211 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which USTEKINUMAB Alternatives Have Lower Thrombocytopenia Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE